Ophthalmic Devices: M&A, Venture Capital & Private Equity Activity



With an estimated value of over $53bn, the sizeable global ophthalmic devices market continues to show robust growth. An ageing population with an increasing prevalence of ophthalmic diseases, combined with major technological advancements, is driving demand for ophthalmic devices.


As a result, there has been significant M&A activity in recent years. This report highlights the key M&A, venture capital and private equity activity from across the globe.


A copy of the report can be downloaded here: